基因编辑公司Precision BioSciences Inc. (NASDAQ: DTIL )宣布，Sam Wadsworth博士将于2025年1月23日起从公司董事会退休。该公司市值为3870万美元，目前处于盈利状态。 根据 InvestingPro ...

Precision BioSciences Inc . (NASDAQ:DTIL), a profitable gene editing company with a market capitalization of $38.7 million, has announced the retirement of Dr. Sam Wadsworth from its Board of ...